Archive for Miller

FDA Scientific Stakeholder Workshop Needs Your Input

Dear Patients, Patient’s Loved Ones and Friends, Since I ended my hunger strike, I have learned that the FDA has sent invitations for the ME/CFS scientific stakeholder workshop scheduled for April 25-26th. The FDA hasn’t disclosed who it is inviting, and did not solicit input from patients. You, Read more [...]

Ending My Hunger Strike with Accomplishment

Dear Friends, We, as a community, accomplished some very important things during the last few weeks, and so I am ending my hunger strike tonight. I am committed to working with our federal health agencies to bring a stronger focus and program to bear on ME/CFS for all of us. The most important Read more [...]

FDA Denial of Ampligen Exposes Out of Touch Agency; Hemispherx to Appeal

Hemispherx released a statement on Monday indicating the FDA had denied their application of Ampligen to treat Chronic Fatigue Syndrome (ME/CFS) because of lack of   'substantial' proof of efficacy and (rather ominously) because  they did not have enough data to assess safety concerns. The Read more [...]

Hunger Striker Decries FDA Denial of Only Medicine for Chronic Fatigue Syndrome

Ask Secretary Sebelius to start NIH Clinical Trial of Ampligen Contact: Robert Miller 703-554-5575, Courtney Miller 631-834-4681 In day 8 of his hunger strike, Chronic Fatigue Syndrome patient Robert Miller decried the FDA’s decision (announced hours ago) to disapprove Ampligen, Read more [...]

Chronic Fatigue Syndrome Hunger Strike Effort to Approve Ampligen Hitting the News

The plight of the chronic fatigue syndrome community was given a sympathetic and moving portrayal in a TV news story in Reno  yesterday that featured Bob Miller and Dr. Janet Smith, another Ampligen recipient.  The news organization contacted both the FDA and Hemispherx regarding the story. Read more [...]

ME/CFS Advocate Begins Hunger Strike For Ampligen Approval

Bob Miller has been to the Vice President's office, he's had one and one meetings with the Director of the NIH, he's canvassed politicians on the Hill - he's thrown everything he can into the fight to get this disorder recognition - but this time, the issue - the probable FDA rejection of Ampligen Read more [...]